Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor

Endocrinology

Volumn 143, Issue 5, 2002, Pages 1677-1685

  Vorwerk, Peter ^a   Hohmann, Bianka ^a   Oh, Youngman ^b   Rosenfeld, Ron G ^b   Shymko, Ronald M ^c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; PROTEIN MAC25; RECOMBINANT PROTEIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; BIOSENSOR; CARBOXY TERMINAL SEQUENCE; INSULIN BINDING; MEASUREMENT; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 0036228553     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.5.8760     Document Type: Article

References (53)

1. The insulin-like growth factor binding protein superfamily: New perspectives
2. Biological actions of proteolytic fragments of the IGF binding proteins
3. Insulin-like growth factor binding protein (IGFBP) proteolysis: Occurrence, identification, role and regulation
4. IGF-independent actions of the IGF binding proteins
5. Insulin-like growth factors and their binding proteins: Biological actions
6. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition
7. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy
8. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: Effects of a pregnancy-associated serum protease activity
9. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action
10. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin
11. Prostate carcinoma (PC-3) cell proliferation is stimulated by the 22-25-kDa proteolytic fragment (1-160) and inhibited by the 16-kDa fragment (1-95) of recombinant human insulin-like growth factor binding protein-3
12. Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine
13. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins
14. A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3
15. Recreating a high affinity insulin-like growth factor binding protein using discrete N- and C-terminal fragments
16. Synthesis of IGFBP-3 fragments in a baculovirus system and characterization of monoclonal anti-IGFBP-3 antibodies
17. Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-β in Hs578T human breast cancer cells
18. Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3
19. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3
20. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily
21. Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP superfamily
22. Localization of an insulin-like growth factor (IGF) binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain
23. Molecular genetics and actions of recombinant insulin-like growth factor binding protein-3
24. Molecular biology and physiology of the insulin-like growth factor binding protein 3, the acid-stable unit of the 150k serum insulin-like growth factor binding komplex
25. Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4
26. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast
27. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6
28. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs
29. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs
30. A rapid, non-radioactive method for the detection of insulin-like growth factor binding proteins by western ligand blotting
31. Detection of serum insulin-like growth factor binding proteins on western ligand blots by biotinylated IGF and enhanced chemiluminescence
32. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling
33. Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3
34. Biosensor analysis of insulin-like growth factor/insulin-like growth factor binding protein interactions
35. Biosensor measurement of IGF-binding to N- and C-terminal recombinant human IGFBP-3 fragments
36. Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins
37. Differential dissociation kinetics explain the binding preference of insulin-like growth factor binding protein-6 for insulin-like growth factor-II over insulin-like growth factor-I
38. Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3
39. Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): Implications for IGF and IGF-I receptor interactions
40. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II
41. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors
42. Kinetics of ligand binding to receptor immobilized in a polymer matrix, as detected with an evanescent wave biosensor. I. A computer simulation of the influence of mass transport
43. Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors
44. Reliable determination of binding affinity and kinetics using surface plasmon resonance biosensors
45. Experimental-design for kinetic-analysis of protein-protein interactions with surface-plasmon resonance biosensors
46. Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules
47. Biosensor analysis of drug-target interactions: Direct and competitive binding assays for investigation of interactions between thrombin and thrombin inhibitors
48. A model for insulin binding to the insulin receptor
49. Mechanism of insulin and IGF-I receptor activation and signal transduction specificity. Receptor dimer cross-linking, bell-shaped curves, and sustained versus transient signaling
50. Antigen-antibody binding and mass transport by convection and diffusion to a surface: A two-dimensional computer model of binding and dissociation kinetics
51. Analysis of mass transport-limited binding-kinetics in evanescent-wave biosensors
52. Insulin-like growth factor binding proteins from human plasma
53. Insulin-like growth factor (IGF) binding protein-3 in pregnancy serum binds native IGF-I but not iodo-IGF-I